Your session is about to expire
← Back to Search
Implantable Device
Beacon Aqueous Microshunt for Glaucoma (Beacon Trial)
N/A
Waitlist Available
Research Sponsored by MicroOptx
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Beacon Trial Summary
This trial will test a new type of glaucoma surgery to see if it is safe and effective.
Beacon Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness via Intraocular Pressure Reduction
Safety via Serious and Adverse Event Reporting
Secondary outcome measures
Kaplan-Meier Analysis of Failure
Mean Change from baseline in IOP
Number of topical IOP-lowering medications - Mean change from baseline
+4 moreBeacon Trial Design
1Treatment groups
Experimental Treatment
Group I: Beacon Aqueous MicroshuntExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
MicroOptxLead Sponsor
2 Previous Clinical Trials
18 Total Patients Enrolled
2 Trials studying Glaucoma
18 Patients Enrolled for Glaucoma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger